Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
05.09.2013 16:14:00

Cerner to Integrate Elsevier's Evidence-Based Clinical Content

PHILADELPHIA, Pennsylvania, September 5, 2013 /PRNewswire/ --

Elsevier's order sets, care plans and clinical documentation to be offered to current and future Cerner PowerChart EHR customers

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today a reseller agreement with Cerner to integrate Elsevier's evidence-based clinical content into Cerner's PowerChart® electronic health record (EHR).

Through this agreement, Elsevier's clinical content solutions will be available to Cerner's current and prospective PowerChart® EHR clients. These solutions include InOrder by Elsevier, an intuitive, cloud-based order sets system, and Elsevier's CPM CarePoints, which provides evidence-based, workflow-enhancing clinical guidance for quality care.

"Health care providers face many challenges, including how to give their clinicians every advantage when it comes to evidence-based clinical information, order sets, guidelines and documentation," said Jim Stewart, a Senior Director at Cerner. "We're enthusiastic about making the Elsevier content solutions available to our clients."

This new agreement also expands an existing one between Cerner and Elsevier's ExitCare, an enterprise-wide solution for patient education and discharge instructions. ExitCare, InOrder and CPM are components of Elsevier's integrated suite of clinical decision support and clinical reference solutions, all of which give healthcare providers highly relevant, evidence-based content.

"Elsevier has assembled a suite of clinical decision support and reference products that answer the industry's needs for trusted, comprehensive and convenient clinical information in electronic form," said Jay Katzen, President of Elsevier Clinical Solutions. "Our agreement with Cerner makes much of this suite available to a growing number of the most progressive healthcare institutions around the world."

InOrder by Elsevier drives quality care by enabling physicians, clinicians and informaticists to author, review and manage order sets in a collaborative environment. It adapts to healthcare organizations' through terminology services that allow you to import your existing order sets and author order sets based upon your hospital's terminology and order items.

Elsevier's CPM CarePoints promotes a patient-centered, interprofessional approach to care by providing clinicians with point of care access to evidence-based guidelines, care planning and clinical documentation tools for 250 medical, surgical and human response diagnoses. CPM CarePoints' EHR-based system provides an all-inclusive framework for implementing evidence-based practice across all clinical domains.

For more information on the integration of Elsevier's clinical content with Cerner, please contact Jim Stewart at +1-816-201-2239 or at JStewart@cerner.com.

About Cerner

Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.

Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.

Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN. For more information about Cerner, please visit http://www.cerner.com, Twitter, Facebook and YouTube.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL

Media contacts
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com

Megan Moriarty
Public Relations/Media
Cerner
+1-816-888-2470
Megan.moriarty@cerner.com

SOURCE Elsevier

Nachrichten zu Reed Elsevier plc (Spons. ADRs)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Reed Elsevier plc (Spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!